Cargando…

Thromboelastography during treatment with activated protein C

Detalles Bibliográficos
Autores principales:	Panascia, E, Castiglione, G, Calabrese, P, Saglimbene, S, Panascia, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098496/ http://dx.doi.org/10.1186/cc3409

Ejemplares similares

Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over, multicenter Italian study
por: Bartolini, M, et al.
Publicado: (2013)

Fibrinolysis during cardiopulmonary bypass detected with thromboelastography
por: Hájek, R, et al.
Publicado: (2007)

Thromboelastography may detect hypercoagulation in early sepsis and improve anticoagulation during extracorporeal treatments
por: Turani, F, et al.
Publicado: (2015)

Utilisation review of thromboelastography in intensive care
por: Aron, J, et al.
Publicado: (2015)

Role of thromboelastography in the management of haemorrhage: an observational analysis
por: Ward, C, et al.
Publicado: (2015)

Value of thromboelastography in managing hypercoagulopathy in intensive care
por: Aron, J, et al.
Publicado: (2015)

Role of thromboelastography in septic patients treated with coagulation inhibitor
por: Giarratano, A, et al.
Publicado: (2005)

Thromboelastography (platelet contribution to clot strength) for the assessment of platelet residual function
por: Haxhiademi, D, et al.
Publicado: (2012)

Use of thromboelastography in severe sepsis: a case-control study
por: Cortegiani, A, et al.
Publicado: (2011)

Coagulation profile evaluated by thromboelastography rotem(®) in patients with subarachnoid hemorrhage admitted to an intensive care unit
por: Gomez Builes, JC, et al.
Publicado: (2015)

Rotational thromboelastography in a patient with heparin-induced thrombocytopenia: a case report
por: Silva, EA, et al.
Publicado: (2007)

Thromboelastography versus viscoelastography for evaluation of coagulopathies in patients after abdominal surgery for cancer
por: Tarabrin, O, et al.
Publicado: (2009)

Thromboelastography in clinical decision-making in the critically ill patient in a district general hospital ICU
por: Louw, J, et al.
Publicado: (2008)

Biochemical and hematological parameters (including thromboelastography) differ in patients with sepsis and SIRS after esophagectomy
por: Durila, M, et al.
Publicado: (2011)

Urokinase-induced fibrinolysis in thromboelastography (UKIF-TEG) to assess fibrinolysis in critically ill patients
por: Zacchetti, L, et al.
Publicado: (2013)

Templating effect of clot structure can predict clot development and outcome in diluted blood: a comparison with thromboelastography
por: Lawrence, M, et al.
Publicado: (2012)

A243 THROMBOELASTOGRAPHY-GUIDED COAGULOPATHY CORRECTION IN CIRRHOTIC PATIENTS DECREASES BLOOD PRODUCT TRANSFUSION: A SYSTEMATIC REVIEW AND ANALYSIS
por: Komeylian, H, et al.
Publicado: (2023)

Tissue perfusion evaluation with near-infrared spectroscopy during treatment with activated protein C
por: Donati, A, et al.
Publicado: (2008)

Activated protein C: cost matters!
por: Dravid, T, et al.
Publicado: (2010)

Disturbed alveolar fibrin turnover during pneumonia is associated with reduced activated protein C levels in lungs
por: Choi, G, et al.
Publicado: (2004)

Activated protein C in sepsis: an Indian experience
por: Abraham, B, et al.
Publicado: (2005)

Activated protein C–protein C inhibitor complex as a prognostic marker in sepsis
por: Heslet, Lars, et al.
Publicado: (2008)

Activated protein C–protein C inhibitor complex as a prognostic marker in sepsis
por: Heslet, L, et al.
Publicado: (2009)

Human protein C concentrate in the treatment of hemolytic uremic syndrome
por: Sasse, M, et al.
Publicado: (2007)

The effect of activated protein C on experimental acute necrotizing pancreatitis
por: Yamanel, L, et al.
Publicado: (2005)

Identification of cCMP binding and activated proteins
por: Wolfertstetter, Stefanie, et al.
Publicado: (2013)

Protein C in murine neonatal sepsis
por: Muchitsch, E, et al.
Publicado: (2005)

Risk/benefit analysis of activated protein C in patients with intra-abdominal sepsis
por: Borthwick, E, et al.
Publicado: (2007)

Influence of corticosteroids on C-reactive protein in patients with rheumatoid arthritis
por: Mysler, E, et al.
Publicado: (2004)

Testing of anti-activated protein C antibodies in four drotrecogin alfa (activated) severe sepsis studies
por: Yan, S, et al.
Publicado: (2008)

Human protein C concentrate in the treatment of hemolytic uremic syndrome
por: Wermter, Burkhard, et al.
Publicado: (2007)

Activated protein C, severe sepsis and 28-day mortality
por: De La Torre-Prados, M, et al.
Publicado: (2012)

Recombinant human activated protein C upregulates cyclooxygenase-2 and release of prostaglandins from cultured human endothelial cells via the endothelial protein C receptor
por: Brueckmann, M, et al.
Publicado: (2004)

Activated protein C consumption and coagulation parameters in severe sepsis and septic shock
por: De La Torre-Prados, M, et al.
Publicado: (2014)

Surviving ratio of severe sepsis treated with activated protein C in one university intensive care unit during 2003–2006
por: Tokarz, A, et al.
Publicado: (2007)

Recruitment of IFT proteins during flagellum construction in Trypanosoma brucei
por: Bertiaux, E, et al.
Publicado: (2015)

Activation of cGMP-dependent protein kinase Iα and cAMP-dependent protein kinase A isoforms by cyclic nucleotides
por: Wolter, Sabine, et al.
Publicado: (2011)

Activated protein C restores kidney function in endotoxin-induced acute renal failure in the rat
por: Almac, E, et al.
Publicado: (2009)

Activated protein C improves intestinal microcirculation in experimental endotoxemia in the rat
por: Knöck, A, et al.
Publicado: (2005)

Activation profile of cGMP-dependent protein kinase Iα
por: Wolter, Sabine, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gd892lj0crf84h0glq54ovme4d